DERMATITIS TREATING AGENT (AS AMENDED)

The present invention is to provide a topical dermatitis treating agent which comprises a pyridine compound represented by the following formula [I]: wherein R1 and R2 each represent a lower alkoxy group, X- represents a group represented by the formula: or a group represented by the formula: N-, Ri...

Full description

Saved in:
Bibliographic Details
Main Authors NAOTSUKA ATSUKO, KIKUCHI MATSUO
Format Patent
LanguageEnglish
Published 27.05.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is to provide a topical dermatitis treating agent which comprises a pyridine compound represented by the following formula [I]: wherein R1 and R2 each represent a lower alkoxy group, X- represents a group represented by the formula: or a group represented by the formula: N-, Ring A represents a saturated or unsaturated bicyclic nitrogen-containing heterocyclic group having 1 to 4 substituents selected from hydroxyl group, oxo group, a lower alkoxy group, a di-lower alkylaminophenyl group, a pyperidino-lower alkoxy group, a morpholino-lower alkoxy group, a cyclo-lower alkylamino-lower alkylamino group, pyridyl group and morpholino group, and represents a single bond or a double bond, or a pharmaceutically acceptable salt thereof as an active ingredient.
AbstractList The present invention is to provide a topical dermatitis treating agent which comprises a pyridine compound represented by the following formula [I]: wherein R1 and R2 each represent a lower alkoxy group, X- represents a group represented by the formula: or a group represented by the formula: N-, Ring A represents a saturated or unsaturated bicyclic nitrogen-containing heterocyclic group having 1 to 4 substituents selected from hydroxyl group, oxo group, a lower alkoxy group, a di-lower alkylaminophenyl group, a pyperidino-lower alkoxy group, a morpholino-lower alkoxy group, a cyclo-lower alkylamino-lower alkylamino group, pyridyl group and morpholino group, and represents a single bond or a double bond, or a pharmaceutically acceptable salt thereof as an active ingredient.
Author KIKUCHI MATSUO
NAOTSUKA ATSUKO
Author_xml – fullname: NAOTSUKA ATSUKO
– fullname: KIKUCHI MATSUO
BookMark eNrjYmDJy89L5WRQc3EN8nUM8QzxDFYICXIFsvzcFRzdXf1CFDQcgxUcfV39XFxdNHkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYGhsYGJpYmjoTFxqgAXGCXF
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2010130494A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2010130494A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2010130494A13
Notes Application Number: US20060089295
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100527&DB=EPODOC&CC=US&NR=2010130494A1
ParticipantIDs epo_espacenet_US2010130494A1
PublicationCentury 2000
PublicationDate 20100527
PublicationDateYYYYMMDD 2010-05-27
PublicationDate_xml – month: 05
  year: 2010
  text: 20100527
  day: 27
PublicationDecade 2010
PublicationYear 2010
Score 2.7715504
Snippet The present invention is to provide a topical dermatitis treating agent which comprises a pyridine compound represented by the following formula [I]: wherein...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DERMATITIS TREATING AGENT (AS AMENDED)
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100527&DB=EPODOC&locale=&CC=US&NR=2010130494A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIJS9KFI28TqQ5GuSbcJ7Uabyd5Gm6YgyByu4r_vtbS6p70dF7h8wOXud5e7ANzKQtHcTKkh0doaxJLUSGWmjNxxCmRlJqFVcXIYPY5m5HVO5x34aGth6j6hP3VzRNQoifpe1vf16j-Ixeq3leuH7B1Zny-BcJneoGOzinI6Ohu4fDphE1_3fXeW6FFcj5lVSol4iJV20JF2Kn3gb4OqLmW1aVSCQ9idorxleQQdtezBvt_-vdaDvbBJeSPZaN_6GHTG49ATYzFONBFzpKKh5g15JLQ7L9G8kEeMs_sTuAm48EcGTrj4299ilmyuzj6FLiJ_dQaaZdsFQTyQZjYlVpo_ZdYzOjTKKtJCEmqfQ3-bpIvtw5dw0KbCLacP3fLrW12hhS2z6_pgfgFq93o0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhTnG86FadTC0rRhyJtE6sPQ7om3aprN9pM9laargVB5nAV_77X0ume9nbcweUSuNxX7gJwk-YZnesJ1VK0thoxUqolqcy0uWXliJI6oWVzsh88DKfkZUZnDfhY98JUc0J_quGIqFEp6ntR3dfL_yQWq95Wru7lO6I-n13RY2odHetlltNSWb_HJ2M2dlTH6U0jNQgrml6WlIiNsdIOOtlWqQ_8rV_2pSw3jYp7ALsT5LcoDqGRLdrQctZ_r7Vhz69L3gjW2rc6ApXx0LeFJ7xIESFHKBgo9oAHQrm1I8X2ecA4uzuGa5cLZ6jhgvHf_uJptCmdeQJNjPyzU1AM08wJippIkxIjmT9K4wkdmszIkzwl1OxAdxuns-3kK2gNhT-KR17weg7767K4YXWhWXx9ZxdobQt5WR3SL1EkfSc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DERMATITIS+TREATING+AGENT+%28AS+AMENDED%29&rft.inventor=NAOTSUKA+ATSUKO&rft.inventor=KIKUCHI+MATSUO&rft.date=2010-05-27&rft.externalDBID=A1&rft.externalDocID=US2010130494A1